114 related articles for article (PubMed ID: 20477643)
1. Prostate autoimmunity: from experimental models to clinical counterparts.
Penna G; Fibbi B; Maggi M; Adorini L
Expert Rev Clin Immunol; 2009 Sep; 5(5):577-86. PubMed ID: 20477643
[TBL] [Abstract][Full Text] [Related]
2. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
3. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Kramer G; Mitteregger D; Marberger M
Eur Urol; 2007 May; 51(5):1202-16. PubMed ID: 17182170
[TBL] [Abstract][Full Text] [Related]
4. Characterization of circulating CD4+CD25high regulatory T cells in men with chronic prostatitis/chronic pelvic pain syndrome.
Bai J; Wang S; Liu J; Ye Z; Yu X; Xi Q; Hu D; Su S
Urology; 2010 Apr; 75(4):938-42. PubMed ID: 19800664
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
Fibbi B; Penna G; Morelli A; Adorini L; Maggi M
Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330
[TBL] [Abstract][Full Text] [Related]
6. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
7. Could inflammation be a key component in the progression of benign prostatic hyperplasia?
Kramer G; Marberger M
Curr Opin Urol; 2006 Jan; 16(1):25-9. PubMed ID: 16385197
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune prostatitis: state of the art.
Motrich RD; Maccioni M; Riera CM; Rivero VE
Scand J Immunol; 2007; 66(2-3):217-27. PubMed ID: 17635799
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms in prostatitis/chronic pelvic pain syndrome.
Pontari MA; Ruggieri MR
J Urol; 2008 May; 179(5 Suppl):S61-7. PubMed ID: 18405756
[TBL] [Abstract][Full Text] [Related]
10. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation.
Penna G; Fibbi B; Amuchastegui S; Cossetti C; Aquilano F; Laverny G; Gacci M; Crescioli C; Maggi M; Adorini L
J Immunol; 2009 Apr; 182(7):4056-64. PubMed ID: 19299703
[TBL] [Abstract][Full Text] [Related]
11. Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity.
John H; Maake C; Barghorn A; Zbinden R; Hauri D; Joller-Jemelka HI
Andrologia; 2003 Oct; 35(5):294-9. PubMed ID: 14535858
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins.
Alexander RB; Brady F; Ponniah S
Urology; 1997 Dec; 50(6):893-9. PubMed ID: 9426720
[TBL] [Abstract][Full Text] [Related]
13. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis.
Nadler RB; Koch AE; Calhoun EA; Campbell PL; Pruden DL; Bennett CL; Yarnold PR; Schaeffer AJ
J Urol; 2000 Jul; 164(1):214-8. PubMed ID: 10840462
[TBL] [Abstract][Full Text] [Related]
14. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.
Nickel JC; Alexander RB; Schaeffer AJ; Landis JR; Knauss JS; Propert KJ;
J Urol; 2003 Sep; 170(3):818-22. PubMed ID: 12913707
[TBL] [Abstract][Full Text] [Related]
15. Properties and origin of human Th17 cells.
Romagnani S; Maggi E; Liotta F; Cosmi L; Annunziato F
Mol Immunol; 2009 Nov; 47(1):3-7. PubMed ID: 19193443
[TBL] [Abstract][Full Text] [Related]
16. Correlation between benign prostatic hyperplasia and inflammation.
Bostanci Y; Kazzazi A; Momtahen S; Laze J; Djavan B
Curr Opin Urol; 2013 Jan; 23(1):5-10. PubMed ID: 23159991
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
18. [Benign prostate hyperplasia with chronic prostatitis: an update].
Ma Y; Zhang WL
Zhonghua Nan Ke Xue; 2010 Jul; 16(7):646-50. PubMed ID: 20873602
[TBL] [Abstract][Full Text] [Related]
19. Patients with chronic prostatitis/chronic pelvic pain syndrome show T helper type 1 (Th1) and Th17 self-reactive immune responses specific to prostate and seminal antigens and diminished semen quality.
Motrich RD; Breser ML; Molina RI; Tissera A; Olmedo JJ; Rivero VE
BJU Int; 2020 Sep; 126(3):379-387. PubMed ID: 32437049
[TBL] [Abstract][Full Text] [Related]
20. IL-17 is not essential for inflammation and chronic pelvic pain development in an experimental model of chronic prostatitis/chronic pelvic pain syndrome.
Motrich RD; Breser ML; Sánchez LR; Godoy GJ; Prinz I; Rivero VE
Pain; 2016 Mar; 157(3):585-597. PubMed ID: 26882345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
